Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
131
-
Total shares
-
26.2M
-
Shares change
-
-173K
-
Total reported value, excl. options
-
$492M
-
Value change
-
-$4.78M
-
Put/Call ratio
-
5.37
-
Number of buys
-
68
-
Number of sells
-
-53
-
Price
-
$18.75
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q3 2020
132 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q3 2020.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.2M shares
of 50.5M outstanding shares and own 51.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.9M shares), FEDERATED HERMES, INC. (2.74M shares), VANGUARD GROUP INC (2.41M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), Invesco Ltd. (1.35M shares), STATE STREET CORP (1.29M shares), FULLER & THALER ASSET MANAGEMENT, INC. (818K shares), GEODE CAPITAL MANAGEMENT, LLC (542K shares), GOLDMAN SACHS GROUP INC (539K shares), and NORTHERN TRUST CORP (511K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.